• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Orexigen Therapeutics Inc

+ Add to Watchlist


5.4100 USD 0.1300 2.46%

As of 20:10:00 ET on 01/23/2015.

Snapshot for Orexigen Therapeutics Inc (OREX)

Open: 5.4500 Day's Range: 5.3200 - 5.6800 Volume: 5,406,279
Previous Close: 5.2800 52wk Range: 3.1100 - 7.8200 1-Yr Rtn: -20.21%

Stock Chart for OREX

No chart data available.
  • OREX:US 5.4100
  • 1D
  • 1M
  • 1Y
Interactive OREX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OREX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5600
Est. EPS (USD) (12/2014) -0.1030
Est. PEG Ratio -
Market Cap (M USD) 666.33
Shares Outstanding (M) 123.17
30 Day Average Volume 2,701,616
Price/Book (mrq) 39.4330
Price/Sale (ttm) 19.6546
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OREX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OREX

Orexigen Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of the central nervous system (CNS) disorders with an initial focus on obesity.

Michael Narachi "Mike"President/CEOMark D BoothChief Commercial Officer
Joseph P Hagan "Jay"Chief Bus Officer/Acting CFOHeather D TurnerSenior VP/Secretary/Gen Cnsl
More Company Profile & Key Executives for OREX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil